Septic Shock Clinical Trial
Official title:
Resuscitation Strategies in Septic Shock. A Randomized Controlled Trial of Two Different Fluid Loading Strategies in ICU Patients With Early Septic Shock
The purpose of this study, in mechanically ventilated septic shock patients, is to determine whether a fluid loading strategy based on parameters derived from the transpulmonary thermodilution technique may lead to more ventilator free days compared to a fluid loading strategy based on the surviving sepsis guidelines.
Rationale: Fluid loading is an important intervention in patients with severe sepsis and
septic shock in order to prevent development of multi organ failure and mortality. The
Surviving Sepsis Guidelines recommend during the first 6 hours of resuscitation a central
venous pressure (CVP) based fluid loading approach, targeting to 12-15 mmHg in mechanically
ventilated patients. CVP however has proven to be a poor indicator for preload and preload
dependency, while dynamic parameters as stroke volume variation (SVV) derived from the
transpulmonary thermodilution technique (TPTD) are superior. Together with the ability to
measure the extravascular lung water (EVLW), the TPTD technique may guide fluid management
more accurately and may prevent deleterious fluid overloading.
Objective: The risk of fluid overloading in mechanically ventilated patients with septic
shock is less when fluid administration is based on a fluid loading protocol using SVV
together with EVLW measurements than applying the Surviving Sepsis Guidelines targeting CVP
to 12-15 mmHg, in at least the first 6 hours of resuscitation, translating in more
ventilator free days (VFDs) Study design: This is a prospective, randomized, non-blinded,
single-center, controlled clinical trial comparing two different fluid resuscitation
strategies in patients with septic shock. Patients will be randomized for fluid management
based on the Surviving Sepsis Guidelines (SSG) or based transpulmonary thermodilution (TPTD)
derived SVV and EVLW in at least the first 6 hours of resuscitation.
Study population: All patients of ≥18 years admitted to the ICU because of septic shock
together with the need for mechanical ventilation are eligible for randomization
Intervention: During at least the first 6 hours of resuscitation, the standard group (SSG
guided therapy) follows a fluid resuscitation protocol based on the Surviving Sepsis
Campaign recommendations. Initial trigger for fluid loading when circulatory insufficiency
is present will be the CVP (target ≥12 mmHg). The intervention group (TPTD guided therapy)
follows a fluid resuscitation protocol based on SVV and EVLW. Initial trigger for fluid
loading when circulatory insufficiency is present will be SVV. The study protocol will be
applied up to a maximum of 72 hours.
Main study parameters/endpoints: VFDs on day 28. Benefit and risks associated with
participation: Since inclusion criteria include a TPTD (5F fiber optic, femoral artery)
catheter, the inconvenience as compared to standard treatment is minimal. Current routine
hospital policy involves TPTD catheter insertion in most of the patients meeting the
inclusion criteria specified above.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03649633 -
Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock
|
Phase 1/Phase 2 | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Completed |
NCT05629780 -
Temporal Changes of Lactate in CLASSIC Patients
|
N/A | |
Recruiting |
NCT04796636 -
High-dose Intravenous Vitamin C in Patients With Septic Shock
|
Phase 1 | |
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Recruiting |
NCT05066256 -
LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 | |
Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Recruiting |
NCT02565251 -
Volemic Resuscitation in Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT02676427 -
Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination
|
||
Recruiting |
NCT02580240 -
Administration of Hydrocortisone for the Treatment of Septic Shock
|
N/A | |
Terminated |
NCT02335723 -
ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber
|
N/A | |
Not yet recruiting |
NCT02547467 -
TOADS Study: TO Assess Death From Septic Shock.
|
N/A | |
Completed |
NCT02638545 -
Hemodynamic Effects of Dexmedetomidine in Septic Shock
|
Phase 3 | |
Completed |
NCT02306928 -
PK Analysis of Piperacillin in Septic Shock Patients
|
N/A | |
Completed |
NCT02204852 -
Co-administration of Iloprost and Eptifibatide in Septic Shock Patients
|
Phase 2 |